Patent intelligence · US
US 10184931
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
Patent details — US 10184931
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 22, 2019
- Expiration
- Jan 17, 2039
- Applicant
- Aytu BioScience, Inc.
- Claims
- 5
- CPC classes
- A61K, A61K35/16
Quick answer
US 10184931 (Methods and systems for measuring and using the oxidation-reduction potential of a biological sample) is held by Aytu BioScience, Inc.. Status: granted. Granted Jan 22, 2019. Expires Jan 17, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Aytu BioScience, Inc.
- Grant date
- Expiration
- Claims
- 5
- CPC classes
- A61K, A61K35/16
More from Aytu BioScience, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 11534474
Oral compositions for bladder regulation and uses thereof
granted -
US 9410913
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted -
US 9360446
Methods and systems for measuring and using the oxidation-reduction potential of a biological sample
granted
Frequently asked questions
What is US patent 10184931?
US 10184931 (Methods and systems for measuring and using the oxidation-reduction potential of a biological sample) is held by Aytu BioScience, Inc.. Status: granted. Granted Jan 22, 2019. Expires Jan 17, 2039 (13 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 10184931?
Aytu BioScience, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 4 pharmaceutical patents for this assignee.
When does US 10184931 expire?
Our index shows an expiration date of Jan 17, 2039 (13 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.